US20210139844A1
University of North Texas Health Science Center
Certain aspects of the current invention are directed to a reprogramming of somatic cells to provide therapeutic cells for treatment of diseases such as retinopathies. Certain aspects of the invention are directed to reprogramming compositions, as well as the use of such compositions, for …